Skip to main content

PRTT status update announcement.

Written by Customer Service on . Posted in Public Companies.

Cheyenne, Wyoming, Dec. 12, 2022 (GLOBE NEWSWIRE) — Protect Pharmaceutical Corporation, Inc. (OTC:PRTT) informs, that the Share Exchange Agreement №1, signed on June 15, 2022 was not executed due to the insufficiency of legal instruments on the territory of the Republic of Belarus for conducting such transactions, and terminated on December 6, 2022.

The absence of an established agreement between the US and Belarus depositories and the lack of a legal basis for conducting transactions on the international exchange of securities caused the inability to perform the obligations.

According to par. 2.2-2.4 of the Agreement, the Parties shall had executed all legal obligations within 60 working days from the date of execution of the Agreement. As per September 6th, 2022 the obligations were not executed, and Parties agreed to extend the period for three more months.

As per December 6, 2022 the obligations were not executed, and the Parties mutually agreed to terminate the Agreement.

None of the terms of Agreement have been fulfilled by any of the Parties. The Parties have no claims against each other.

PRTT has prepared adjusted financial statements for the period of 2 and 3 quarters of 2022, taking into account the absence of any new assets and liabilities, based on the terms of termination of the Agreement.

About PRTT

Protect Pharmaceutical Corporation is a full-cycle software development and delivery company that produces, releases, and supports digital products for the business-to-business and business-to-consumer markets. The company’s expertise lies in custom software development and consulting services in Business automation, Artificial Intelligence, Machine Learning, Data Science, Big Data, Image recognition, Blockchain development, and cloud services. Its domain focus includes Supply chain, Logistics, Healthcare, Finance, Real estate, Legal, Insurance, Advertising, and more.

For more information contact:
Protect Pharmaceutical Corporation, Inc.
(347) 692 8942
business@inaiapp.com

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.